• Published On : Dec-2014 |
  • Pages : 92 Pages |
  • Format :

Table of Content

Chapter 1 Preface

1.1 Report Description

1.2 Research Methodology

1.3 Assumptions

Chapter 2 Market Synopsis

Chapter 3 Porter’s Five Forces Analysis

3.1 Bargaining Power of Suppliers

3.2 Bargaining Power of Buyers

3.3 Threat of New Entrants

3.4 Threat of Substitutes

3.5 Intensity of Rivalry

Chapter 4 Industry Overview

4.1 Market Definition

4.2 Market Drivers

     4.2.1 Increasing prevalence of chronic diseases

     4.2.2 Rising aging population

     4.2.3 Increasing initiatives undertaken by various government associations spreading awareness about importance of blood donations

     4.2.4 Advanced features of disposable plastic blood bags

4.3 Impact Analysis of Market Drivers

4.4 Market Restraints

     4.4.1 Risks associated with blood transfusion and lack of awareness

     4.4.2 Poor blood collection and storage infrastructure in various parts of the world

     4.4.3 Lack of primary healthcare infrastructure in developing countries

4.5 Impact Analysis of Market Restraints

4.6 Market Trends

     4.6.1 Increasing number of mergers and acquisitions

     4.6.2 Increasing use of RFID technology in blood bags

4.7 Market Opportunities

     4.7.1 Usage of non-PVC materials in blood bag

Chapter 5 Global Market Size and Forecast

5.1 On the Basis of Geography

5.2 On the Basis of Type

5.3 On the Basis of End Users

Chapter 6 Market Size and Forecast by Type

6.1 Single Blood Bags

6.2 Double Blood Bags

6.3 Triple Blood Bags

6.4 Quadruple Blood Bags

Chapter 7 Market Size and Forecast by End Users

7.1 Hospital and Healthcare Institutes

7.2 Blood Banks

7.3 Home Healthcare

Chapter 8 Market Size and Forecast by Geography

8.1 North America

8.2 Europe

8.3 Asia

Chapter 9 Competitive Scenario

9.1 Competitive Benchmarking

9.2 Company Share Analysis

Chapter 10 Company Profiles

10.1 Haemonetics Corporation

       10.1.1 Company overview

       10.1.2 Products and services

       10.1.3 Financial performance

       10.1.4 Key developments

10.2 Grifols, S.A.

       10.2.1 Company overview

       10.2.2 Products and services

       10.2.3 Financial performance

       10.2.4 Key developments

10.3 JMS Co., Ltd.

       10.3.1 Company overview

       10.3.2 Products and services

       10.3.3 Financial performance

       10.3.4 Key developments

10.4 Kawasumi Laboratories, Inc.

       10.4.1 Company overview

       10.4.2 Products and services

       10.4.3 Financial performance

       10.4.4 Key developments

10.5 AdvaCare Pharma

       10.5.1 Company overview

       10.5.2 Products and services

       10.5.3 Financial performance

       10.5.4 Key developments

10.6 Fresenius SE & Co. KGaA

       10.6.1 Company overview

       10.6.2 Products and services

       10.6.3 Financial performance

       10.6.4 Key developments

10.7 Terumo Corporation

       10.7.1 Company overview

       10.7.2 Products and services

       10.7.3 Financial performance

       10.7.4 Key developments

10.8 MacoPharma, S.A.

       10.8.1 Company overview

       10.8.2 Products and services

       10.8.3 Financial performance

       10.8.4 Key developments

10.9 GenesisBPS

       10.9.1 Company overview

       10.9.2 Products and services

       10.9.3 Financial performance

       10.9.4 Key development

10.10 SURU International Pvt. Ltd.

       10.10.1 Company overview

       10.10.2 Products and services

       10.10.3 Financial performance

       10.10.4 Key developments

10.11 Shanghai Transfusion Technology Co., Ltd.

       10.11.1 Company overview

       10.11.2 Products and services

       10.11.3 Financial performance

       10.11.4 Key developments

10.12 Sichuan Nigale Biomedical Co., Ltd.

       10.12.1 Company overview

       10.12.2 Products and services

       10.12.3 Financial performance

       10.12.4 Key developments

10.13 Neomedic Limited

       10.13.1 Company overview

       10.13.2 Products and services

       10.13.3 Financial performance

       10.13.4 Key developments

10.14 Shandong Weigao Group Medical Polymer Co., Ltd.

       10.14.1 Company overview

       10.14.2 Products and services

       10.14.3 Financial performance

       10.14.4 Key developments


List of Table

TABLE 1 Market snapshot: Global market of disposable plastic blood bags (2014 and 2020) 11

TABLE 2 Drivers for disposable plastic blood bags market: Impact analysis 21

TABLE 3 Restraints for disposable plastic blood bags market: Impact analysis 24

TABLE 4 Some of the major mergers and acquisitions in disposable plastic blood bags market 25

TABLE 5 Global disposable plastic blood bags market size, by region, 2010 – 2013 (USD thousand) 29

TABLE 6 Global disposable plastic blood bags market size, by region, 2014 – 2020 (USD thousand) 29

TABLE 7 Global disposable plastic blood bags market size, by type, 2010 – 2013 (USD thousand) 31

TABLE 8 Global disposable plastic blood bags market size, by type, 2014 – 2020 (USD thousand) 31

TABLE 9 Global disposable plastic blood bags market size, by end users, 2010 – 2013 (USD thousand) 33

TABLE 10 Global disposable plastic blood bags market size, by end users, 2014 – 2020 (USD thousand) 33

TABLE 11 Global single blood bags market size, by region, 2010 – 2013 (USD thousand) 35

TABLE 12 Global single blood bags market size, by region, 2014 – 2020 (USD thousand) 35

TABLE 13 Global double blood bags market size, by region, 2010 – 2013 (USD thousand) 37

TABLE 14 Global double blood bags market size, by region, 2014 – 2020 (USD thousand) 37

TABLE 15 Global triple blood bags market size, by region, 2010 – 2013 (USD thousand) 38

TABLE 16 Global triple blood bags market size, by region, 2014 – 2020 (USD thousand) 39

TABLE 17 Global quadruple blood bags market size, by region, 2010 – 2013 (USD thousand) 41

TABLE 18 Global quadruple blood bags market size, by region, 2014 – 2020 (USD thousand) 41

TABLE 19 Global hospital and healthcare institutes market size, by region, 2010 – 2013 (USD thousand) 43

TABLE 20 Global hospital and healthcare institutes market size, by region, 2014 – 2020 (USD thousand) 43

TABLE 21 Global blood banks market size, by region, 2010 – 2013 (USD thousand) 44

TABLE 22 Global blood banks market size, by region, 2014 – 2020 (USD thousand) 45

TABLE 23 Global home healthcare market size, by region, 2010 – 2013 (USD thousand) 46

TABLE 24 Global home healthcare market size, by region, 2014 – 2020 (USD thousand) 47

TABLE 25 North American disposable plastic blood bags market size, by country, 2010 – 2013 (USD thousand) 49

TABLE 26 North American disposable plastic blood bags market size, by country, 2014 – 2020 (USD thousand) 50

TABLE 27 European disposable plastic blood bags market size, by country, 2010 – 2013 (USD thousand) 52

TABLE 28 European disposable plastic blood bags market size, by country, 2014 – 2020 (USD thousand) 53

TABLE 29 Asian disposable plastic blood bags market size, by country, 2010 – 2013 (USD thousand) 55

TABLE 30 Asian disposable plastic blood bags market size, by country, 2014 – 2020 (USD thousand) 56

TABLE 31 Products and services categories of Haemonetics Corporation 60

TABLE 32 Products and services categories of Grifols, S.A. 62

TABLE 33 Products and services categories of JMS 66

TABLE 34 Products and services categories of Kawasumi Laboratories, Inc. 68

TABLE 35 Products and service categories of AdvaCare Pharma 70

TABLE 36 Products and services categories of Fresenius SE & Co. KGaA 72

TABLE 37 Products and services categories of Terumo Corporation 75

TABLE 38 Products and service categories of MacoPharma, S.A. 77

TABLE 39 Products and service categories of GenesisBPS 79

TABLE 40 Products and service categories of SURU International Pvt. Ltd. 81

TABLE 41 Plasma and blood products and services categories of Sichuan Nigale Biomedical Co., Ltd. 85

TABLE 42 Plasma and blood products and services categories of Neomedic Limited 88

TABLE 43 Products and services categories of Weigao Group 89


List of Figure


FIG. 1 Disposable plastic blood bags market: Porter’s five force analysis 13

FIG. 2 Disposable plastic blood bags market, by type 16

FIG. 3 Aging population in major countries, 2000 – 2050 (% share in total population) 19

FIG. 4 Global disposable plastic blood bags market share, by region, by value, 2013 28

FIG. 5 Global disposable plastic blood bags market share, by type, by value, 2013 30

FIG. 6 Global disposable plastic blood bags market share, by end users, by value, 2013  32

FIG. 7 Global single blood bags market share, by region, by value, 2013 34

FIG. 8 Global double blood bags market share, by region, by value, 2013 36

FIG. 9 Global triple blood bags market share, by region, by value, 2013 38

FIG. 10 Global quadruple blood bags market share, by region, by value, 2013 40

FIG. 11 Global hospital and healthcare institutes market share, by region, by value, 2013  42

FIG. 12 Global blood banks market share, by region, by value, 2013 44

FIG. 13 Global home healthcare market share, by region, by value, 2013 46

FIG. 14 North American disposable plastic blood bags market share, by country, by value, 2013 49

FIG. 15 European disposable plastic blood bags market share, by country, by value, 2013  52

FIG. 16 Asian disposable plastic blood bags market share, by country, by value, 2013 55

FIG. 17 Competitive landscape of disposable plastic blood bag providers, 2013 57

FIG. 18 Global disposable plastic blood bags market, by company, 2013 (% share) 58

FIG. 19 Haemonetics Corporation’s net revenue and net income, 2012 – 2014 (USD million) 60

FIG. 20 Grifols’ net sales and profit after tax, 2011 – 2013 (USD million) 64

FIG. 21 JMS’ net sales and net income, 2012 – 2014 (USD million) 67

FIG. 22 Kawasumi Laboratories, Inc.’s net sales and net income, 2012 – 2014 (USD million) 69

FIG. 23 Fresenius SE & Co. KGaA’s sales and net income, 2011 – 2013 (USD billion) 73

FIG. 24 Terumo Corporation’s net sales and net income, 2012 – 2014 (USD million) 76

FIG. 25 Weigao Group’s revenue and profit, 2011 – 2013 (USD million) 90